VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim’s models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages several parameters studied simultaneously New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim’s models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages several parameters studied simultaneously